Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a retrospective study

BACKGROUND: To optimize treatment, choosing the appropriate relative dose intensity (RDI) of nab-paclitaxel is an important way to improve patient tolerance, therapeutic efficacy, and survival. However, few studies have focused on the efficacy of the RDI of nab-paclitaxel in patients with advanced p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Lian, Shen, Xiao-Ming, Huang, Tie-Ao, Li, Da-Peng, Li, Xian-Min, Han, Shu-Guang, Xu, Xue-Fei, Ma, Chun-Tao, Zhou, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372206/
https://www.ncbi.nlm.nih.gov/pubmed/35966303
http://dx.doi.org/10.21037/tcr-22-1604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372206/
https://www.ncbi.nlm.nih.gov/pubmed/35966303
http://dx.doi.org/10.21037/tcr-22-1604

Ejemplares similares